Dr. Jenab-Wolcott is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Cooper Plz
Camden, NJ 08103Phone+1 855-632-2667Fax+1 302-738-5917
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2007 - 2010
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2003 - 2006
- Tufts University School of MedicineClass of 2003
Certifications & Licensure
- MD State Medical License 2013 - 2026
- NY State Medical License 2024 - 2026
- DE State Medical License 2013 - 2025
- NJ State Medical License 2013 - 2025
- PA State Medical License 2007 - 2024
- CT State Medical License 2006 - 2020
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Start of enrollment: 2010 Mar 01
- Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Start of enrollment: 2010 Jun 01
- Combination Chemotherapy Plus Bevacizumab With or Without Oxaliplatin in Treating Older Patients With Metastatic Colorectal Cancer Start of enrollment: 2011 Jan 01
Publications & Presentations
PubMed
- 2 citationsAntiangiogenic therapy in colorectal cancer: where are we 5 years later?Jenia Jenab-Wolcott, Bruce J. Giantonio
Clinical Colorectal Cancer. 2010-06-01 - 51 citationsBevacizumab: current indications and future development for management of solid tumorsJenia Jenab-Wolcott, Bruce J. Giantonio
Expert Opinion on Biological Therapy. 2009-04-03 - 8 citationsThe absence of Msh2 alters abelson virus pre-B-cell transformation by influencing p53 mutation.Jenia Jenab-Wolcott, Daniel Rodriguez-Correa, Armin Reitmair, Tak W. Mak, Naomi Rosenberg
Molecular and Cellular Biology. 2000-11-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: